| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/02/2013 | CA2715143C Novel phenylpyrrole derivative |
| 04/02/2013 | CA2585642C Carbazole derivatives, solvates thereof, or pharmaceutically acceptable salts thereof |
| 04/02/2013 | CA2575689C Tr1 cells for use in atherosclerosis |
| 04/02/2013 | CA2556805C Use of factor xiii for stimulating the perfusion of ischemic tissue |
| 04/02/2013 | CA2555792C Therapeutic administration of the scrambled anti-angiogenic peptide c16y |
| 04/02/2013 | CA2550843C Novel phenylalanine derivatives |
| 04/02/2013 | CA2538075C Base-substituted benzylamine analogs for use as coagulation factor xa inhibitors, the production and use thereof |
| 04/02/2013 | CA2514948C Use of the enantiomer (1s, 2r) of milnacipran for the preparation of a medicament |
| 04/02/2013 | CA2475633C Heteroaryl compounds useful as inhibitors of gsk-3 |
| 04/02/2013 | CA2470920C Liposomal delivery of vitamin e based compounds |
| 04/02/2013 | CA2457611C Novel molecular target for neurotoxicity |
| 04/02/2013 | CA2452529C Use of a blood-flow decrease preventing agent in conjunction with insufflating gas |
| 04/02/2013 | CA2420652C Vertebrate intestinal protein which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 03/28/2013 | WO2013043960A1 Compounds useful as inhibitors of choline kinase |
| 03/28/2013 | WO2013043085A1 Pharmaceutical substance (variants) and compositions based thereon which exhibit modulatory activity with a commensurate effect |
| 03/28/2013 | WO2013042067A1 Process for the preparation of potassium salt of azilsartan medoxomil |
| 03/28/2013 | WO2013041944A1 Process for the preparation of micronized candesartan cilexetil |
| 03/28/2013 | WO2013041859A1 Cannabinoid-2-receptor agonists |
| 03/28/2013 | WO2013041719A1 Tripeptide kdpt for antiapoptotic treatment |
| 03/28/2013 | WO2013041677A1 Combination therapy using immunoglobulin and c1-inhibitor |
| 03/28/2013 | WO2013041591A1 New bicyclic dihydroquinoline-2-one derivatives |
| 03/28/2013 | WO2013041205A1 Novel therapeutic concepts for treating vascular diseases |
| 03/28/2013 | WO2013040801A1 Hydroxamic acid compound containing quinolyl and preparation method thereof, and pharmaceutical composition containing this compound and use thereof |
| 03/28/2013 | WO2013016720A3 Novel substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases |
| 03/28/2013 | WO2013010034A3 Methods for treating inflammation and hypertension with gamma-ketoaldehyde skavengers |
| 03/28/2013 | WO2012176172A3 Combination therapy with psd-95 inhibitor for ischemia |
| 03/28/2013 | WO2012166463A3 Aminooxazole inhibitors of cyclin dependent kinases |
| 03/28/2013 | WO2012165900A3 Peptide bfp 4 for promoting bone formation or vasculogenesis, and application therefor |
| 03/28/2013 | WO2012146736A8 Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease |
| 03/28/2013 | US20130079514 "omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells" |
| 03/28/2013 | US20130079406 Therapeutic compositions |
| 03/28/2013 | US20130079377 Aryl or N-heteroaryl Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands |
| 03/28/2013 | US20130079373 Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands |
| 03/28/2013 | US20130079365 New bicyclic dihydroquinoline-2-one derivatives |
| 03/28/2013 | US20130079332 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker |
| 03/28/2013 | US20130079321 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
| 03/28/2013 | US20130079317 Methods for treatment of diseases |
| 03/28/2013 | CA2858033A1 Quinolyl-containing hydroxamic acid compound and preparation method thereof, and pharmaceutical composition containing this compound and use thereof |
| 03/28/2013 | CA2849711A1 Compound having modulatory activity with a commensurate effect, pharmaceutical substance (variants), application of pharmaceutical substance, pharmaceutical and parapharmaceuticalformulation (variants), method of preparation of pharmaceutical compositions |
| 03/28/2013 | CA2849442A1 Compounds useful as inhibitors of choline kinase |
| 03/28/2013 | CA2848510A1 Combination therapy using immunoglobulin and c1-inhibitor |
| 03/28/2013 | CA2845183A1 Tripeptide kdpt for antiapoptotic treatment |
| 03/28/2013 | CA2845170A1 New bicyclic dihydroquinoline-2-one derivatives |
| 03/27/2013 | EP2573113A2 Oxidant resistant apolipoprotein a-1 and mimetic peptides |
| 03/27/2013 | EP2573078A1 Acrylamide compounds and use thereof for inhibiting apoptosis |
| 03/27/2013 | EP2571988A1 Compositions for use in treating or diagnosing bone disorders and/or cardiovascular disorders |
| 03/27/2013 | EP2571884A2 Mtor selective kinase inhibitors |
| 03/27/2013 | EP2571881A1 Pyrrolopyrazine derivatives as syk and jak inhibitors |
| 03/27/2013 | EP2571879A1 Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes |
| 03/27/2013 | EP2571870A1 Ccr2 antagonists and uses thereof |
| 03/27/2013 | EP2571853A1 Inhibitors of human 12-lipoxygenase |
| 03/27/2013 | EP2571532A2 Il-1 binding proteins |
| 03/27/2013 | EP2571531A2 Stabilized fibronectin domain compositions, methods and uses |
| 03/27/2013 | EP2571508A1 Process for producing a shrimp hydrolysate using electrodialysis |
| 03/27/2013 | EP2571502A1 Theobromine for increasing hdl-cholesterol |
| 03/27/2013 | EP2571486A1 Dry powder inhalation composition |
| 03/27/2013 | CN103002924A Compositions, methods and systems for the synthesis and use of imaging agents |
| 03/27/2013 | CN103002923A Stabilized fibronectin domain compositions, methods and uses |
| 03/27/2013 | CN103002904A Anti-angiogenic agent and method of using such agent |
| 03/27/2013 | CN103002871A Malvidin for promoting hair growth |
| 03/27/2013 | CN102994507A Retinitis pigmentosa related gene identification, and product, method and use thereof |
| 03/27/2013 | CN102994500A Methods for treating eye disorders |
| 03/27/2013 | CN102994334A Life-nourishing balsam pear yellow wine |
| 03/27/2013 | CN102994333A Female life nourishing yellow wine |
| 03/27/2013 | CN102994330A Immunity-enhancing shiitake wine |
| 03/27/2013 | CN102994311A Hydromel |
| 03/27/2013 | CN102994221A Method for extracting coix seed oil from coix seed |
| 03/27/2013 | CN102993210A New thienopyridine compound |
| 03/27/2013 | CN102993201A 6-(4-hydroxyl-phenyl)-3-styryl-1H-pyrazole[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitor |
| 03/27/2013 | CN102993195A Substitutional-2-(chroman-6-oxyl) thiazole and application thereof as medicine |
| 03/27/2013 | CN102993178A Isoquinoline compound with Rho kinase inhibition activity and preparation method and application thereof |
| 03/27/2013 | CN102993147A 4-chromone and 4-chromanone compounds and application thereof |
| 03/27/2013 | CN102993125A New kappa-opiate receptor stimulant having protection function on ischemia heart |
| 03/27/2013 | CN102993035A Compound with symmetrical structure as well as synthetic method and application of compound |
| 03/27/2013 | CN102992983A Up-regulator for expression of ATP (adenosine triphosphate)-binding cassette transporter A1 and application thereof |
| 03/27/2013 | CN102988985A Use of miR-146a as blood vessel growth regulation target |
| 03/27/2013 | CN102988959A Modulation of NKG2D |
| 03/27/2013 | CN102988938A Traditional Chinese medicine composition for treating arrhythmia or atrial fibrillation and preparation method thereof |
| 03/27/2013 | CN102988926A Tri-jiao heat-clearing tablet |
| 03/27/2013 | CN102988925A Sophora flower capsule for purging colon and heat toxin |
| 03/27/2013 | CN102988915A Hip bath lotion for treating haemorrhoid |
| 03/27/2013 | CN102988910A Orally-taken traditional Chinese medicine decoction for cardiopalmus inquietude treatment |
| 03/27/2013 | CN102988901A Traditional Chinese medicine composition for treating cerebral arteriosclerosis |
| 03/27/2013 | CN102988893A Health-care traditional Chinese medicine composition for fatty liver |
| 03/27/2013 | CN102988881A Preparation method and application of pulse unblocking tablet |
| 03/27/2013 | CN102988878A Chinese medicinal composition capable of clearing liver and improving vision and preparation method thereof |
| 03/27/2013 | CN102988814A Traditional Chinese medicine preparation for treating coronary heart disease |
| 03/27/2013 | CN102988811A Traditional Chinese medicine for treating hypertension |
| 03/27/2013 | CN102988796A Snakegourd fruit capsules for relieving chest and removing stasis |
| 03/27/2013 | CN102988789A Tablets for regulating qi-flowing for eliminating phlegm |
| 03/27/2013 | CN102988779A Chinese medicine composition for treating hypertensive nephropathy and preparation method and application of Chinese medicine composition |
| 03/27/2013 | CN102988771A Chinese medicine composition for treating hypertension and preparation method of Chinese medicine composition |
| 03/27/2013 | CN102988767A Formula of angina pectoris treatment traditional Chinese medicine |
| 03/27/2013 | CN102988747A Aristida triseta electuary for reducing hypertension, hyperglycemia and hyperlipidemia and preparation method thereof |
| 03/27/2013 | CN102988734A Traditional Chinese medicine for treating cardiac asthma |
| 03/27/2013 | CN102988723A Preparation method and application of yin tonifying and calming tablet |
| 03/27/2013 | CN102988722A American ginseng tablets for boosting qi and nourishing yin |
| 03/27/2013 | CN102988719A Qi tonifying and pulse restoring preparation |
| 03/27/2013 | CN102988698A Traditional Chinese medicine sachet used for treating coronary disease |
| 03/27/2013 | CN102988696A Traditional Chinese medicinal composition used for treating coronary heart disease angina pectoris, and its use |